Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H6N4O5 |
Molecular Weight | 226.1463 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C(=O)NN=CC1=CC=C(O1)[N+]([O-])=O
InChI
InChIKey=AJSKOLZKIUMPPG-YCRREMRBSA-N
InChI=1S/C7H6N4O5/c8-6(12)7(13)10-9-3-4-1-2-5(16-4)11(14)15/h1-3H,(H2,8,12)(H,10,13)/b9-3+
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/4798767
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4798767
Nifuraldezone is an antibacterial compound. It completely mimics the radiosensitizing effect of molecular oxygen in hypoxic mammalian cells in vitro at concentrations in tissue culture medium which showed no measurable acute toxicity.
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4798767
Nifuraldezone has been tested with Chinese hamster cells growing in vitro to determine its toxicity and radiosensitizing effectiveness. The most effective compound tested was nifuraldezone which at 250 μm in complete medium gave the same extent of radiosensitization (ER∼2·85) as oxygen in the air-saturated medium.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3184
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
PRIMARY | |||
|
530
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
PRIMARY | |||
|
221-890-9
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
PRIMARY | |||
|
DTXSID6046399
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
PRIMARY | |||
|
3270-71-1
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
PRIMARY | |||
|
C77051
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
PRIMARY | |||
|
CHEMBL1358619
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
PRIMARY | |||
|
18637
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
PRIMARY | |||
|
0180PBK4FC
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
PRIMARY | |||
|
100000083868
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
PRIMARY | |||
|
m845
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB09259MIG
Created by
admin on Fri Dec 15 15:01:27 GMT 2023 , Edited by admin on Fri Dec 15 15:01:27 GMT 2023
|
PRIMARY |
ACTIVE MOIETY